The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Flow Cytometry)
Description
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others)
In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing and mass spectrometry.
The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of disease as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed.
This Kalorama report contains market sizes and forecasts for these technologies, identifies drivers and market trends, and identifies the competitive situation in the market. Kalorama's analysis is the result of detailed research into secondary literature and primary interviews to develop reliable business planning information for entrants or investors in this market. Over 25 Company profiles are included as part of the research in this report.
In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing and mass spectrometry.
The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of disease as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed.
This Kalorama report contains market sizes and forecasts for these technologies, identifies drivers and market trends, and identifies the competitive situation in the market. Kalorama's analysis is the result of detailed research into secondary literature and primary interviews to develop reliable business planning information for entrants or investors in this market. Over 25 Company profiles are included as part of the research in this report.
Table of Contents
110 Pages
- SEGMENTS COVERED
- ADVANCED TECHNOLOGIES
- SIZE AND GROWTH IN THE MARKET
- Worldwide Molecular Histology/Cytology Sales, by Type, 2015 and 2020 (in situ hybridization, HPV, Tissue Microarrays, CTC, Flow Cytometry) (sales $ million)
- MARKET BY GEOGRAPHIC REGION
- SAMPLE PREPARATION
- IN SITU HYBRIDIZATION
- HPV TESTING
- CIRCULATING TUMOR CELLS
- FLOW CYTOMETRY
- PHARMACODIAGNOSTIC HISTOLOGY
- ABBOTT DIAGNOSTICS
- ADVANCED CELL DIAGNOSTICS (ACD)
- AMOY DIAGNOSTICS CO. LTD.
- APPLIED SPECTRAL IMAGING INC. (ASI)
- BECKMAN COULTER, INC. / DANAHER
- BECTON, DICKINSON AND COMPANY (BD)
- BIOVIEW LTD.
- CIRCULOMICS INC.
- COVARIS INC.
- CYMOGEN DX, LLC
- DAKO A/S
- DEFINIENS
- DXTERITY DIAGNOSTICS INC.
- GENERAL ELECTRIC - GE HEALTHCARE
- HOLOGIC, INC.
- HTG MOLECULAR DIAGNOSTICS
- JANSSEN DIAGNOSTICS
- KAPA BIOSYSTEMS INC.
- LEICA BIOSYSTEMS
- PRETECT AS (FORMERLY NORCHIP)
- QIAGEN N.V.
- ROCHE DIAGNOSTICS
- SONY BIOTECHNOLOGY ( ICYT )
- SYSMEX CORPORATION
- VENTANA MEDICAL SYSTEMS INC.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
